• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Enzyme Inhib Med Chem . Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?

tetano

Editor, Senior Moderator
J Enzyme Inhib Med Chem


. 2022 Dec;37(1):1077-1082.
doi: 10.1080/14756366.2022.2062336.
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?


Matteo Pavan[SUP] 1 [/SUP], Davide Bassani[SUP] 1 [/SUP], Mattia Sturlese[SUP] 1 [/SUP], Stefano Moro[SUP] 1 [/SUP]



Affiliations

Abstract

Despite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat coronaviruses with a high degree of genome similarity with SARS-CoV-2, especially concerning the RBDs of the S protein, which mediates the capability of such viruses to enter and therefore infect human cells through a hACE2-dependent pathway. These viruses, especially the one named BANAL-236, showed a higher affinity for the hACE2 compared to the original strain of SARS-CoV-2. In the present work, we analyse the similarities and differences between the 3CL protease (main protease, M[SUP]pro[/SUP]) of these newly reported viruses and SARS-CoV-2, discussing their relevance relative to the efficacy of existing therapeutic approaches against COVID-19, particularly concerning the recently approved orally available Paxlovid, and the development of future ones.

Keywords: BANAL; Laos; MPro; Paxlovid; SARS-CoV-2; bat coronavirus; sarbecovirus.
 
Back
Top Bottom